GARRETT JONES: Open Payments
NPI 1760865216 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 47 payments from 8 companies in 2025. Trend: 2023 $523 · 2024 $585 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $270 |
| Lundbeck LLC | 10 | $192 |
| Valinor Pharma, LLC | 5 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $72 |
| PFIZER INC. | 3 | $46 |
| Abbott Laboratories | 1 | $24 |
| Forte Bio-Pharma LLC | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: VYEPTI, QULIPTA, MOVANTIK, RELISTOR, BOTOX, UBRELVY, NURTEC ODT, ETERNA.
Industry payments across MS — which companies pay providers there.
